New York Life Insurance Company:企業のM&A・事業提携・投資動向

◆英語タイトル:New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1362
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

New York Life Insurance Company – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by New York Life Insurance Company since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes New York Life Insurance Company’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by New York Life Insurance Company. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on New York Life Insurance Company’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by New York Life Insurance Company and its subsidiaries since 2007.
- Information about key financial and legal advisors for New York Life Insurance Company’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about New York Life Insurance Company’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 14
Corporate Venturing – Overview 14
Corporate Venturing – Deal reports 15
CAPITAL RAISING 76
Capital Raising – Overview 76
Capital Raising – Deal reports 77
DIVESTMENTS 80
Divestments – Overview 80
Divestments – Deal reports 81
APPENDIX 101
Contact Us 101
About MarketLine Financial Deals Database 101
Deal Definition and Methodology 103
About MarketLine 110

List of Tables
Table 1: New York Life Insurance Company M&A volume and value trend (2014-YTD2018)
Table 2: New York Life Insurance Company M&A activity by geography (2014-YTD2018)
Table 3: New York Life Insurance Company corporate venturing volume and value trend (2014-YTD2018)
Table 4: New York Life Insurance Company corporate venturing by geography (2014-YTD2018)
Table 5: New York Life Insurance Company capital raising volume and value trend (2014-YTD2018)
Table 6: New York Life Insurance Company capital raising by deal type (2014-YTD2018)
Table 7: New York Life Insurance Company divestments volume and value trend (2014-YTD2018)
Table 8: New York Life Insurance Company divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: New York Life Insurance Company M&A volume and value trend (2014-YTD2018)
Figure 2: New York Life Insurance Company M&A activity by geography (2014-YTD2018)
Figure 3: New York Life Insurance Company corporate venturing volume and value trend (2014-YTD2018)
Figure 4: New York Life Insurance Company corporate venturing by geography (2014-YTD2018)
Figure 5: New York Life Insurance Company capital raising volume and value trend (2014-YTD2018)
Figure 6: New York Life Insurance Company capital raising by deal type (2014-YTD2018)
Figure 7: New York Life Insurance Company divestments volume and value trend (2014-YTD2018)
Figure 8: New York Life Insurance Company divestments by geography (2014-YTD2018)

★海外企業調査レポート[New York Life Insurance Company:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • National Grid Plc (NG):石油・ガス:M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pacific World Corporation:企業の戦略・SWOT・財務情報
    Pacific World Corporation - Strategy, SWOT and Corporate Finance Report Summary Pacific World Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Treatt Plc:企業の戦略・SWOT・財務分析
    Treatt Plc - Strategy, SWOT and Corporate Finance Report Summary Treatt Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • Bayer Healthcare Pharmaceuticals:企業の戦略・SWOT・財務情報
    Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report Summary Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cimarex Energy Co.:企業の戦略・SWOT・財務分析
    Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report Summary Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Entercom Communications Corp (ETM):企業の財務・戦略的SWOT分析
    Summary Entercom Communications Corp (Entercom) is a provider of media and entertainment services. The company offers radio broadcasting programs. It owns and operates radio stations in various formats, including classic rocks, sports, news, talk, adult contemporary, alternative and country and othe …
  • L E Pritchitt & Co Ltd. :企業の戦略・SWOT・財務情報
    L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JSW Steel Ltd:企業の戦略・SWOT・財務情報
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務分析
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Westport Fuel Systems Inc.:企業のM&A・事業提携・投資動向
    Westport Fuel Systems Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westport Fuel Systems Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Capsugel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • BELLUS Health Inc (BLU):製薬・医療:M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆